{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:06:21Z","timestamp":1779221181679,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,19]]},"DOI":"10.7759\/cureus.109214","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:15:26Z","timestamp":1779218126000},"source":"Crossref","is-referenced-by-count":0,"title":["Investigation of Potential Splenic Metastasis on Prostate-Specific Membrane Antigen (PSMA) Imaging in High-Risk Prostate Cancer: A Role for MRI?"],"prefix":"10.7759","author":[{"given":"Carson H","family":"Neal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chance L","family":"Matthiesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Key Statistics for Prostate Cancer. American Cancer Society. (2026). Accessed. September 4, 2025: https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html."},{"key":"ref2","unstructured":"Cancer Stat Facts. Prostate Cancer. National Cancer Institute. (2026). Accessed: September 4, 2025: https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5539\/gjhs.v6n7p49","article-title":"Survey of clinical and pathological characteristics and outcomes of patients with prostate cancer","volume":"6","author":"Alizadeh M","year":"2014","unstructured":"Alizadeh M, Alizadeh S. Survey of clinical and pathological characteristics and outcomes of patients with prostate cancer. Glob J Health Sci. 2014, 6:49-57. 10.5539\/gjhs.v6n7p49","journal-title":"Glob J Health Sci"},{"key":"ref4","article-title":"Clinical presentation and diagnosis of prostate cancer","author":"Taplin","year":"2025","unstructured":"Taplin, ME, Smith JA. Clinical presentation and diagnosis of prostate cancer. UpToDate. Robert Lee W, Richie JP, Sartor AO (ed): Wolters Kluwer, 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","author":"Gandaglia G","year":"2014","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, et al.. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014, 74:210-6. 10.1002\/pros.22742","journal-title":"Prostate"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0193","article-title":"Induction of PSMA and internalization of an anti-PSMA mAb in the vascular compartment","volume":"14","author":"Nguyen DP","year":"2016","unstructured":"Nguyen DP, Xiong PL, Liu H, et al.. Induction of PSMA and internalization of an anti-PSMA mAb in the vascular compartment. Mol Cancer Res. 2016, 14:1045-53. 10.1158\/1541-7786.MCR-16-0193","journal-title":"Mol Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231182293","article-title":"The current status of prostate cancer treatment and PSMA theranostics","volume":"15","author":"Uemura M","year":"2023","unstructured":"Uemura M, Watabe T, Hoshi S, Tanji R, Yaginuma K, Kojima Y. The current status of prostate cancer treatment and PSMA theranostics. Ther Adv Med Oncol. 2023, 15:17588359231182293. 10.1177\/17588359231182293","journal-title":"Ther Adv Med Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel FL","year":"2017","unstructured":"Giesel FL, Hadaschik B, Cardinale J, et al.. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2017, 44:678-88. 10.1007\/s00259-016-3573-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.22038\/AOJNMB.2023.72138.1505","article-title":"Tubarial salivary glands on PSMA ligands based PET imaging and post (177)Lu PSMA therapy scan: reiterating its importance","volume":"12","author":"Kumar SA","year":"2024","unstructured":"Kumar SA, Meena A, Sood A, Kumar R, Mittal BR. Tubarial salivary glands on PSMA ligands based PET imaging and post (177)Lu PSMA therapy scan: reiterating its importance. Asia Ocean J Nucl Med Biol. 2024, 12:43-5. 10.22038\/AOJNMB.2023.72138.1505","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2020.06.031","article-title":"Fluorine-18 labelled prostate-specific membrane antigen (PSMA)-1007 positron-emission tomography-computed tomography: normal patterns, pearls, and pitfalls","volume":"75","author":"Foley RW","year":"2020","unstructured":"Foley RW, Redman SL, Graham RN, Loughborough WW, Little D. Fluorine-18 labelled prostate-specific membrane antigen (PSMA)-1007 positron-emission tomography-computed tomography: normal patterns, pearls, and pitfalls. Clin Radiol. 2020, 75:903-13. 10.1016\/j.crad.2020.06.031","journal-title":"Clin Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa F","year":"2020","unstructured":"de Galiza Barbosa F, Queiroz MA, Nunes RF, et al.. Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer Imaging. 2020, 20:23. 10.1186\/s40644-020-00300-7","journal-title":"Cancer Imaging"},{"key":"ref12","unstructured":"NCCN Clinical Practice Guidelines in Oncology - Prostate Cancer. National Comprehensive Cancer Network. (2025). Accessed. October 25, 2025: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000096942","article-title":"Late recurrence of a prostatic adenocarcinoma as a solitary splenic metastasis","volume":"78","author":"Comp\u00e9rat E","year":"2007","unstructured":"Comp\u00e9rat E, Azzouzi AR, Chartier-Kastler E, M\u00e9n\u00e9gaux F, Capron F, Richard F, Charlotte F. Late recurrence of a prostatic adenocarcinoma as a solitary splenic metastasis. Urol Int. 2007, 78:86-8. 10.1159\/000096942","journal-title":"Urol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70751","article-title":"Unusual prostate-specific membrane antigen (PSMA) splenic uptake in a patient with prostate cancer","volume":"16","author":"Athiraman H","year":"2024","unstructured":"Athiraman H, Miller K, Guido J, Borghero Y. Unusual prostate-specific membrane antigen (PSMA) splenic uptake in a patient with prostate cancer. Cureus. 2024, 16:e70751. 10.7759\/cureus.70751","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.59566\/IJBS.2009.5085","article-title":"Primary tumors of the spleen","volume":"5","author":"Fotiadis C","year":"2009","unstructured":"Fotiadis C, Georgopoulos I, Stoidis C, Patapis P. Primary tumors of the spleen. Int J Biomed Sci. 2009, 5:85-91.","journal-title":"Int J Biomed Sci"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.5455\/annalsmedres.2018.04.058","article-title":"The incidence of splenic hemangioma and its rupture risk","volume":"25","author":"Gundogan E","year":"2018","unstructured":"Gundogan E, Sansal M, Gunes O, Akinci EC, Erkenekli TE, Sumer F. The incidence of splenic hemangioma and its rupture risk. Ann Med Res. 2018, 25:368-70.","journal-title":"Ann Med Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman MS","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, et al.. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020, 395:1208-16. 10.1016\/S0140-6736(20)30314-7","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/219297","article-title":"The spleen revisited: an overview on magnetic resonance imaging","volume":"2013","author":"Palas J","year":"2013","unstructured":"Palas J, Matos AP, Ramalho M. The spleen revisited: an overview on magnetic resonance imaging. Radiol Res Pract. 2013, 2013:219297. 10.1155\/2013\/219297","journal-title":"Radiol Res Pract"},{"key":"ref19","article-title":"Splenectomy","author":"Yi SL","year":"2025","unstructured":"Yi SL, Buicko Lopez JL. Splenectomy. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424451-investigation-of-potential-splenic-metastasis-on-prostate-specific-membrane-antigen-psma-imaging-in-high-risk-prostate-cancer-a-role-for-mri","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:15:30Z","timestamp":1779218130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424451-investigation-of-potential-splenic-metastasis-on-prostate-specific-membrane-antigen-psma-imaging-in-high-risk-prostate-cancer-a-role-for-mri"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.109214","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}